Financial results - MEDICAL MEDMUN AG SRL

Financial Summary - Medical Medmun Ag Srl
Unique identification code: 15944872
Registration number: J03/1580/2003
Nace: 8622
Sales - Ron
72.259
Net Profit - Ron
50.688
Employee
1
The most important financial indicators for the company Medical Medmun Ag Srl - Unique Identification Number 15944872: sales in 2023 was 72.259 euro, registering a net profit of 50.688 euro and having an average number of 1 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Medical Medmun Ag Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 60.799 62.151 63.737 65.218 72.012 64.299 55.235 53.772 57.502 72.259
Total Income - EUR 60.799 62.450 64.004 65.300 72.166 64.600 55.549 58.793 57.705 73.247
Total Expenses - EUR 14.472 14.876 17.025 16.777 15.898 17.007 14.930 15.839 17.704 21.915
Gross Profit/Loss - EUR 46.328 47.574 46.979 48.523 56.267 47.593 40.619 42.954 40.000 51.332
Net Profit/Loss - EUR 44.504 45.701 45.699 47.870 55.546 46.947 40.108 42.378 39.435 50.688
Employees 2 2 2 1 1 1 1 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 26.0%, from 57.502 euro in the year 2022, to 72.259 euro in 2023. The Net Profit increased by 11.373 euro, from 39.435 euro in 2022, to 50.688 in the last year.

Check the financial reports for the company - Medical Medmun Ag Srl

Rating financiar

Financial Rating -
Medical Medmun Ag Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Medical Medmun Ag Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Medical Medmun Ag Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Medical Medmun Ag Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Medical Medmun Ag Srl - CUI 15944872

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 0 801 726 1.589 1.187 799 425 355 295 2.461
Current Assets 48.513 49.013 48.963 50.052 48.425 47.800 43.824 45.937 44.044 47.460
Inventories 0 0 0 0 39 38 0 65 65 65
Receivables 2.499 2.775 3.160 5.231 6.150 5.273 3.110 4.502 40.317 8.646
Cash 46.014 46.238 45.804 44.821 42.236 42.489 40.713 41.371 3.662 38.750
Shareholders Funds 3.840 3.872 49.531 51.638 49.518 48.355 43.666 45.857 42.925 49.773
Social Capital 45 45 45 44 43 42 41 40 41 40
Debts 44.673 45.942 158 3 94 243 582 435 1.414 148
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 47.460 euro in 2023 which includes Inventories of 65 euro, Receivables of 8.646 euro and cash availability of 38.750 euro.
The company's Equity was valued at 49.773 euro, while total Liabilities amounted to 148 euro. Equity increased by 6.978 euro, from 42.925 euro in 2022, to 49.773 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Medical Medmun Ag Srl

Comments - Medical Medmun Ag Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.